Table 1.
Individual | MCT12 Mutation | SGLT2 Mutation | Age (Years) | Plasma Parameters | 24-Hour Urinary Glucose Excretion | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Na | K | Cl | Ca | P | Mg | pH | HCO3 | Glucose | Creatinine | CKD-EPI eGFR | Cystatin C | Cystatin eGFR | Hb A1c | |||||
II-1 | yes | yes | 70.3 | 138 | 4.1 | 108 | 2.27 | 1.12 | 0.89 | 7.35 | 24.3 | 5.2 | 67 | 80 | 1.07 | 64 | 5.6 | 6.71 |
II-3 | yes | yes | 65.3 | 138 | 3.8 | 106 | 2.22 | 1.08 | 0.82 | 7.39 | 28.7 | 4.9 | 52 | 96 | 0.90 | 82 | 6.3 | 11.77 |
II-7 | yes | yes | 61.8 | 139 | 4.5 | 102 | 2.26 | 0.83 | 0.83 | 7.29 | 25.2 | 4.5 | 66 | 86 | 0.70 | 103 | 5.6 | 5.54 |
III-4 | yes | yes | 40.2 | 137 | 3.9 | 100 | 2.24 | 0.85 | 0.72 | 7.40 | 23.5 | 4.8 | 66 | 100 | 0.53 | 130 | 5.7 | 6.53 |
III-7 | yes | yes | 27.1 | 140 | 4.8 | 106 | 2.25 | 0.84 | 0.85 | 7.34 | 26.7 | 5.1 | 91 | 99 | 0.80 | 119 | 5.4 | 1.10 |
II-5 | yes | no | 55.3 | 141 | 3.9 | 104 | 2.27 | 1.01 | 0.78 | 7.43 | 23.0 | 4.4 | 70 | 98 | 0.86 | 90 | 5.4 | 0.14 |
II-9 | yes | no | 69.4 | 137 | 4.3 | 99 | 2.38 | 1.00 | 0.76 | 7.36 | 28.0 | 9.7 | 96 | 69 | 0.87 | 90 | 7.8 | 32.48 |
III-1 | yes | no | 44.8 | 138 | 4.2 | 103 | 2.31 | 0.85 | 0.88 | 7.39 | 29.1 | 4.7 | 69 | 92 | 0.96 | 81 | 5.7 | 0.09 |
III-2 | yes | no | 43.3 | 141 | 4.1 | 107 | 2.29 | 0.74 | 0.79 | 7.37 | 26.7 | 4.9 | 74 | 107 | 0.73 | 117 | 5.6 | 0.36 |
III-5 | yes | no | 22.4 | 140 | 3.6 | 101 | 2.24 | 1.05 | 0.77 | 7.37 | 24.8 | 3.7 | 61 | 106 | 0.74 | 118 | 5.4 | 0.12 |
III-8 | yes | no | 35.6 | 139 | 4.4 | 106 | 2.15 | 1.16 | 0.83 | 7.39 | 22.9 | 4.7 | 85 | 76 | 0.85 | 99 | 4.7 | 0.55 |
II-2 | no | no | 68.6 | 137 | 4.0 | 107 | 2.23 | 1.06 | 0.70 | 7.41 | 21.7 | 6.4 | 73 | 90 | 0.90 | 86 | 6.9 | 0.10 |
II-4 | no | no | 74.4 | 142 | 4.1 | 102 | 2.27 | 1.04 | 0.80 | 7.39 | 26.5 | 5.4 | 80 | 83 | 0.93 | 81 | 6.1 | 0.27 |
II-8 | no | no | 64.7 | 139 | 4.4 | 102 | 2.22 | 0.78 | 0.87 | 7.36 | 25.6 | 4.9 | 74 | 92 | 0.73 | 107 | 5.4 | 0.33 |
II-10 | no | no | 70.4 | 138 | 4.2 | 103 | 2.26 | 0.96 | 0.78 | 7.40 | 24.6 | 5.0 | 63 | 86 | 0.74 | 97 | 5.7 | 0.19 |
II-11 | no | no | 53.7 | 136 | 4.1 | 101 | 2.29 | 0.70 | 0.77 | 7.41 | 23.9 | 5.4 | 94 | 79 | 0.79 | 108 | 5.4 | 0.39 |
III-6 | no | no | 30.5 | 138 | 3.9 | 108 | 2.20 | 0.82 | 0.76 | 7.37 | 24.9 | 5.2 | 77 | 89 | ND | ND | 5.1 | 0.36 |
III-10 | no | no | 38.7 | 139 | 4.2 | 106 | 2.25 | 0.96 | 0.76 | 7.39 | 25.3 | 4.6 | 74 | 88 | 0.69 | 114 | 5.1 | 0.41 |
III-11 | no | no | 39.5 | 143 | 4.0 | 105 | 2.35 | 0.98 | 0.89 | 7.38 | 27.1 | 4.7 | 75 | 109 | 0.65 | 126 | 5.3 | 0.64 |
III-12 | no | no | 22.6 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | 0.18 |
III-13 | no | no | 25.8 | 140 | 4.0 | 102 | 2.29 | 1.15 | 0.88 | 7.40 | 25.1 | 5.1 | 113 | 77 | 0.80 | 120 | 5.2 | 0.18 |
MCT12 mutation yes, median (IQR) | 44.8 (37.9–63.6) | 139 (138–140) | 4.1 (3.9–4.4) | 104 (101.5–106) | 2.26 (2.24–2.28) | 1 (0.85–1.07) | 0.82 (0.78–0.84) | 7.37 (7.36–7.39) | 25.2 (23.9–27.35) | 4.8a (4.6–4.9) | 69 (66–79.5) | 96 (83–100) | 0.85 (0.74–0.89) | 99 (86–117) | 5.6a (5.4–5.7) | 0.83a (0.19–6.3) | ||
MCT12 mutation no, median (IQR) | 46.6 (32.5–67.6) | 139 (138–140) | 4.1 (4–4.2) | 103 (102–106) | 2.26 (2.23–2.29) | 0.96 (0.82–1.04) | 0.78 (0.76–0.87) | 7.39 (7.38–7.4) | 25.1 (24.6–25.6) | 5.11a (4.9–5.4) | 75 (74–80) | 88 (83–90) | 0.77 (0.72–0.83) | 108 (94–116) | 5.4a (5.2–5.7) | 0.27a (0.16–0.38) | ||
Mann–Whitney U test, P value | 1 | 0.97 | 0.82 | 0.91 | 0.94 | 0.57 | 0.62 | 0.18 | 0.62 | 0.03 | 0.14 | 0.41 | 0.41 | 0.66 | 0.46 | 0.19 | ||
SGLT2 mutation yes, median (IQR) | 61.8 (40.2–65.3) | 138 (138–139) | 4.1 (3.9–4.5) | 106 (102–106) | 2.25 (2.24–2.26) | 0.85 (0.84–1.08) | 0.83 (0.82–0.85) | 7.35 (7.34–7.39) | 25.2 (24.3–26.7) | 4.8a (4.8–5.1) | 66 (66–67) | 96 (86–99) | 0.80 (0.70–0.90) | 105 (82–110) | 5.6a (5.6–6.5) | 6.5a (5.5–6.7) | ||
SGLT2 mutation no, median (IQR) | 44 (34.3–65.6) | 139 (138–140.5) | 4.1 (4–4.2) | 103 (102–106) | 2.27 (2.24–2.29) | 0.98 (0.84–1.05) | 0.78 (0.77–0.85) | 7.39 (7.37–7.4) | 25.1 (24.25–26.6) | 4.9a (4.7–5.2) | 74 (71.5–82.5) | 89 (81–95) | 0.80 (0.70–0.90) | 100 (86–109) | 5.4a (5.2–5.7) | 0.27a (0.16–0.38) | ||
Mann–Whitney U test, P value | 0.60 | 0.43 | 0.79 | 0.69 | 0.36 | 0.93 | 0.41 | 0.13 | 0.79 | 1.00 | 0.09 | 0.55 | 1 | 0.89 | 0.16 | 0.001 |
Numbering is according to the pedigree in Figure 1. Raw data, median, and interquartile range (IQR) of all parameters are presented. Between-group differences were analyzed by the Mann–Whitney U test. Plasma Na, K, Cl, P, Mg, HCO3, and glucose are in mmol/l, and plasma creatinine in μmol/l. Glucose excretion per 24 hours in the urine is in mmol. CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; HbA1c, glycated hemoglobin; ND, not determined.
Subject II-9 suffers from diabetes mellitus type II. He was therefore excluded from the statistical analyses concerning the comparison between patients with and without the SGLT2 mutation for the following parameters: plasma glucose, HbA1c, and glucose excretion per 24 hours.